How the endocannabinoid system influences alcohol addiction and fetal alcohol disorders
A comprehensive review details how alcohol alters the endocannabinoid system, how CB1 receptors contribute to alcohol reward and motivation, and how ECS disruption contributes to fetal alcohol spectrum disorders.
Quick Facts
What This Study Found
Alcohol alters endocannabinoid levels and CB1 receptor expression in brain addiction circuits. CB1 receptors significantly contribute to the motivational and reinforcing properties of alcohol. The ECS also plays a role in fetal alcohol spectrum disorders (FASD), with both acute and chronic alcohol exposure producing relevant alterations in ECS function during development.
Key Numbers
CB1 receptors are present in both inhibitory and excitatory neurons at presynaptic terminals. CB2 receptors are found in microglia, astrocytes, and neuronal subpopulations. Chronic alcohol consumption alters eCB transmitters and CB1R expression in addiction-related brain nuclei.
How They Did This
Comprehensive literature review covering preclinical and clinical studies on the endocannabinoid system role in alcohol use disorders and fetal alcohol spectrum disorders.
Why This Research Matters
Understanding how alcohol hijacks the endocannabinoid system could lead to new treatments for alcohol addiction and prevention strategies for fetal alcohol disorders. CB1 receptor-targeted therapies represent a potential but largely unexplored approach to alcohol use disorders.
The Bigger Picture
The endocannabinoid system sits at a crossroads between cannabis and alcohol research. Understanding how both substances modulate the same system could inform policies around co-use and lead to novel therapeutic strategies targeting shared neurobiological pathways.
What This Study Doesn't Tell Us
Much of the evidence comes from animal models. Translation of preclinical ECS findings to human alcohol use disorders remains limited. The complexity of ECS signaling makes it difficult to predict therapeutic outcomes from mechanistic studies alone.
Questions This Raises
- ?Could CB1 receptor antagonists or inverse agonists treat alcohol addiction without the psychiatric side effects seen with rimonabant?
- ?Does cannabis co-use with alcohol amplify ECS disruption?
- ?Could ECS-targeted interventions prevent fetal alcohol effects?
Trust & Context
- Key Stat:
- Alcohol hijacks the ECS
- Evidence Grade:
- Rated moderate because the review synthesizes a substantial body of preclinical evidence, though clinical translation remains limited.
- Study Age:
- Published in 2019 as a book chapter in Advances in Experimental Medicine and Biology.
- Original Title:
- Endocannabinoid System and Alcohol Abuse Disorders.
- Published In:
- Advances in experimental medicine and biology, 1162, 89-127 (2019)
- Authors:
- Basavarajappa, Balapal S(4)
- Database ID:
- RTHC-01934
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
How does alcohol affect the endocannabinoid system?
Alcohol alters the levels of endocannabinoid molecules and changes CB1 receptor expression in brain regions involved in addiction. These changes contribute to the motivation to keep drinking.
What does this have to do with cannabis?
Cannabis and alcohol both act through the endocannabinoid system. Understanding how they modulate the same biological pathways could explain why they are often co-used and inform treatment approaches for both.
Can endocannabinoid system changes cause fetal alcohol effects?
The review presents evidence that alcohol-induced ECS disruption during development contributes to fetal alcohol spectrum disorders, suggesting the ECS is a key mediator of alcohol developmental toxicity.
Read More on RethinkTHC
- cannabis-dependence-physical-psychological-addiction-science
- cannabis-perception-vs-evidence-gap
- cannabis-use-disorder-test
- cross-addiction-quit-weed-start-drinking
- is-weed-addictive
- is-weed-addictive-science
- quitting-weed-and-alcohol
- rehab-for-weed-addiction-necessary
- signs-of-cannabis-use-disorder
- weed-vape-pen-addiction
Cite This Study
https://rethinkthc.com/research/RTHC-01934APA
Basavarajappa, Balapal S. (2019). Endocannabinoid System and Alcohol Abuse Disorders.. Advances in experimental medicine and biology, 1162, 89-127. https://doi.org/10.1007/978-3-030-21737-2_6
MLA
Basavarajappa, Balapal S. "Endocannabinoid System and Alcohol Abuse Disorders.." Advances in experimental medicine and biology, 2019. https://doi.org/10.1007/978-3-030-21737-2_6
RethinkTHC
RethinkTHC Research Database. "Endocannabinoid System and Alcohol Abuse Disorders." RTHC-01934. Retrieved from https://rethinkthc.com/research/basavarajappa-2019-endocannabinoid-system-and-alcohol
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.